Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

24 Mar 2017 07:00

RNS Number : 3655A
Standard Life Private Eqty Trst PLC
24 March 2017
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2016

 

· The Company's net asset value per ordinary share ("NAV") increased by 4.3% to 361.2p for the quarter ended 31 December 2016

· Realised gains and income during the quarter ended 31 December 2016 were £18.5 million (3.5% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £9.7 million (1.8% of NAV); in addition, there were unrealised foreign exchange losses of £3.6 million (0.7% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2016

· Outstanding commitments were £312.5 million at 31 December 2016

· Liquid resources were £107.4 million at 31 December 2016

 

For the quarter ended 31 December 2016 the Company's NAV increased by 4.3% to 361.2p, from 346.4p at 30 September 2016. At 31 December 2016 the Company's net assets were £555.3 million (30 September 2016 - £532.6 million). NAV total return was 4.3% for the quarter from 1 October 2016 to 31 December 2016.

 

The closing value of the Company's portfolio of 50 private equity fund interests was £447.9 million at 31 December 2016 (30 September 2016 - £433.4 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 31 December 2016 were £6.1 million, comprising £9.7 million of unrealised gains on a constant exchange rate basis and £3.6 million of unrealised foreign exchange losses. The MSCI Europe Index and the FTSE All Share Index (both in sterling) rose by 4.4% and 3.1% respectively during the quarter. The unrealised foreign exchange losses were driven by the Euro depreciating by 1.4% relative to sterling over the quarter.

 

During the quarter ended 31 December 2016 the Company received £30.8 million of distributions (quarter ended 31 December 2015 - £45.1 million) and funded £20.3 million of draw downs (quarter ended 31 December 2015 - £17.0 million). The distributions received during the quarter generated £18.5 million of net realised gains and income, which was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €34.0 million to the IK VIII Fund. The Company also agreed to acquire, through a secondary purchase, an original commitment of €20.0 million to Nordic Capital VII. The purchase price for the fund interest was €22.1 million, equivalent to a small premium of 2.0% to the most recent valuation date of 30 September 2016, adjusted for subsequent cashflows. The Company assumed outstanding commitments of £0.9 million on acquisition. The Company has existing commitments of €15.0 million and €30.0 million to Nordic Capital Fund VII and VIII respectively. This transaction completed on 12 January 2017.

 

The Company had total outstanding commitments to its 50 private equity fund interests of £312.5 million at 31 December 2016 (30 September 2016 - £305.9 million and 49 private equity fund interests). The Manager continues to believe that around £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2016 the Company had liquid resources of £107.4 million comprised of cash and cash equivalents (30 September 2016 - liquid resources of £105.9 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

 

2. Activity since 31 December 2016

 

On 27 January 2017 the Company paid a final dividend for the year ended 30 September 2016 of 3.6p per ordinary share (total for the year of 5.4p per ordinary share). The cost of the final dividend was £5.5 million.

 

During the period from 1 January to 10 March 2017 the Company received £21.8 million of distributions and funded £14.1 million of draw downs.

 

A new commitment of £22.0 million was also made to HgCapital 8 on 15 February.

 

At 10 March 2017 the Company had liquid resources of £91.5 million. The Company also had total outstanding commitments of £326.6 million.

 

The Company's estimated NAV at 28 February 2017 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2017 on or around 8 June 2017.

 

 

For further information please contact:-

 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life plc.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZXLFLDXFLBBD
Date   Source Headline
17th Jan 20207:00 amRNSDoc re. Annual Report
15th Jan 20207:00 amRNSMonth End Net Asset Value(s)
14th Jan 20204:18 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSAnnual Financial Report
6th Jan 202011:31 amRNSQuarterly Disclosure
13th Dec 20197:00 amRNSMonth End Net Asset Value(s)
12th Dec 20197:00 amRNSFourth Quarter Dividend Declaration
14th Nov 20197:00 amRNSMonth end Net Asset Value(s)
12th Nov 20194:22 pmRNSDirector/PDMR Shareholding
1st Nov 20192:45 pmRNSDirector/PDMR Shareholding
14th Oct 201911:00 amRNSMonth End Net Asset Value(s)
3rd Oct 201911:05 amRNSQuarterly Disclosure
27th Sep 20192:50 pmRNSEstimated Net Asset Value at 31 August 2019
27th Sep 20192:44 pmRNSQuarterly Trading Statement
12th Sep 20197:00 amRNSDeclaration of Third Quarter Dividend
29th Aug 20197:05 amRNSCompany Secretary Change
14th Aug 20192:24 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSEstimated Net Asset Value at 31 July 2019
5th Aug 201911:10 amRNSDirector Declaration
30th Jul 201910:53 amRNSDirector/PDMR Shareholding
12th Jul 20197:00 amRNSEstimated Net Asset Value at 30 June 2019
2nd Jul 20191:11 pmRNSQuarterly Disclosure
19th Jun 20197:06 amRNSEstimated Net Asset Value at 31 May 2019
19th Jun 20197:00 amRNSHalf-year Report
13th Jun 20197:00 amRNSDividend Declaration
29th May 201911:30 amRNSUpdate research from QuotedData
15th May 20197:00 amRNSEstimated Net Asset Value as at 30 April 2019
2nd May 201911:02 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNSEstimated Net Asset Value at 31 March 2019
2nd Apr 20193:55 pmRNSQuarterly Disclosure
1st Apr 201910:08 amRNSChange of Depositary
25th Mar 20197:00 amRNSEstimated net asset value as at 28 February 2019
25th Mar 20197:00 amRNSQuarterly Trading Statement
14th Mar 201911:31 amRNSEdison issues review on Standard Life Private
14th Mar 20197:00 amRNSDividend Declaration
14th Feb 20197:00 amRNSEstimated Net Asset Value at 31 January 2019
29th Jan 20194:27 pmRNSDirector/PDMR Shareholding
22nd Jan 20192:17 pmRNSResult of AGM
15th Jan 20197:00 amRNSEstimated Net Asset Value at 31 December 2018
3rd Jan 20192:17 pmRNSQuarterly Disclosure
31st Dec 201811:18 amRNSDividend Declaration
27th Dec 201811:03 amRNSDirector/PDMR Shareholding
18th Dec 201811:27 amRNS2018 Annual Report and AGM
14th Dec 20187:00 amRNSEstimated Net Asset Value at 30 November 2018
12th Dec 20187:00 amRNSAnnual Financial Report
7th Dec 20184:05 pmRNSDirectorate Change
14th Nov 20187:00 amRNSEstimated Net Asset Value at 31 October 2018
6th Nov 20183:27 pmRNSDirector/PDMR Shareholding
2nd Nov 201812:02 pmRNSDirector/PDMR Shareholding
12th Oct 20187:00 amRNSEstimated Net Asset Value at 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.